Impact of Metformin, Statin, Aspirin and Insulin on the Prognosis of Unresectable Hcc Patients Receiving First-Line Lenvatinib or Atezolizumab plus Bevacizumab
AuthID
P-00Z-QR4
P-00Z-QR4
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service